Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial

NCT02169089 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.

NCT NCT02169089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02169089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial
Lead sponsor
University Hospitals Cleveland Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2016
Completion date
April 29, 2022
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis